Table 1 Clinical, socioeconomic, and treatment characteristics of patients related to the quality of life of 81 patients subjected to treatment for breast cancer

Age group,

Mean (SD)

47.5 (9.7)

51.4 (10)

0.161 ^W

 < 40

13

2

62.29 (11.02)

70.67 (11.9)

77.78 (13.25)

63.67 (13.56)

66.78 (9.68)

 40–50

22

7

66.11 (13.24)

72.64 (9.73)

71.03 (16.06)

65.09 (8.36)

68.02 (8.88)

 50-60

17

9

65.82 (10.49)

72.05 (9.38)

70.26 (18.59)

64..42 (11.19)

67.47 (9.59)

 > 60

7

4

63.12 (9.77)

66.67 (14.68)

64.85 (14.01)

60.91 (12.11)

63.48 (9.16)

 p-value

0.426^Q

0.682 ^k

0.679 ^k

0.253 ^k

0.660 ^k

0.461 ^k

Educational level

 Until elementary school

22

12

62.77 (10.72)

70.59 (11.59)

67.25 (17.7)

64.63 (12.75)

65.91 (9.83)

 Until high school

29

8

65.25 (11.52)

70.81 (10.35)

72.97 (15.23)

62.91 (9.42)

66.82 (8.96)

 Until graduation or superior

8

2

70.86 (12.62)

75.33 (9.58)

78 (13.35)

66.25 (8.19)

71.33 (7.6)

 p-value

0.373^Q

0.330 ^k

0.399^k

0.126^k

0.464^k

0.216^k

Marital status

 Single

25

15

64.07 (11.89)

70..25 (11.99)

71 (16.64)

65.31 (11.95)

66.9 (10.34)

 Not single

28

13

65.71 (11.12)

72.28 (9.5)

71.38 (16.28)

62.8 (9.46)

67.09 (8.15)

 p-value

0.352^Q

0.537^w

0.582^w

0.875^w

0.234^w

0.857^w

How is your health?

 Weak

2

0

57.14 (8.08)^a.b

65.00 (7.07)^a.b

43.33 (14.41)^b

51.25 (1.77)^a.b

55.42 (2.95)^b

 Not bad, not good

16

9

58.17 (8.24)^b

63.47 (10.43)^b

64.27(17.41)^a,b

58.80 (9.69)^b

60.47 (7.99)^b

 Good

25

11

68.49 (9.43)^a

75.19 (9.74)^a

74.44 (11.76)^a

67.36 (10.42)^a

70.53 (7.88)^a

 Very good

15

2

68.07 (15.46)^a

75.1 (7.56)^a

76.08 (17.17)^a

65.29 (9.76)^a

69.90 (8.29)^a

 p-value

0.268^Q

0.002^k

<0.001^k

0.016^k

0.002^k

<0.001^k

Comorbidities

 Yes

23

14

64.48 (12.48)

70.00 (13.26)

68.65 (18.85)

63.78 (11.94)

66.15 (11.00)

 No

36

8

65.26 (10.67)

72.35 (8.35)

73.33 (13.79)

64.26 (9.80)

67.71 (7.51)

p-value

0.048^Q

0.661^w

0.721^w

0.181^w

0.830^w

0.605^w

Family income

 Até 1 BM

40

13

63.67 (11.11)

69.94 (10.28)

70.44 (16.36)

62.5 (11.27)

65.69 (9.22)

 De 1 a 2 BM

12

6

65.08 (8.69)

72.78 (11.90)

72.59 (17.84)

65.97 (10..71)

68.24 (9)

 >2 BM

7

3

71.14 (16.13)

75.67 (10.89)

72.67 (14.89)

68.75 (5.8)

71.67 (8.8)

 p-value

0.751^Q

0.540 ^k

0.131 ^k

0.549 ^k

0.093 ^k

0.117 ^k

Mastectomy technique

 Skin and ANC non-sparing

26

25

65.71 (10.84)

71.31 (11.51)

71.37 (17.35)

63.14 (10.12)

66.96 (9.12)

 Skin sparing

15

3

65.4 (10.18)

71.67 (11.04)

73.7 (13.03)

66.11 (12.4)

68.24 (9.57)

 Skin and ANC sparing

10

0

60.29 (15.68)

71.33 (6.32)

64 (16.09)

64 (9.66)

64.75 (8.53)

 Other

2

0

62.86 (20.2)

66.67 (14.14)

80 (18.86)

68.75 (22.98)

67.92 (19.45)

 p-value

0.509 ^k

0.921 ^k

0.471 ^k

0.557 ^k

0.755 ^k

Breast reconstruction

 Yes

65.62 (11.74)

71.69 (9.97)

72.77 (15.82)

64.62 (10.88)

67.7 (9.02)

 No

62.99 (10.71)

70.15 (12.91)

66.97 (17.39)

62.5 (10.55)

65.11 (9.76)

 p-value

0.536^w

0.616^w

0.166^w

0.343^w

0.310^w

Neoadjuvant therapy

 Chemotherapy

30

8

63.68 (12.12)

71.4 (11)

71.4 (16.18)

64.54 (11.36)

66.86 (9.22)

 Chemotherapy and radiotherapy

2

1

81.9 (19.02)

71.11 (18.36)

71.11 (3.85)

61.67 (8.78)

71.11 (13.39)

 None

27

13

64.79 (9.38)

71.17 (10.31)

71 (17.32)

63.75 (10.52)

66.81 (9.16)

 p-value

0.509^Q

0.230 ^k

0.935 ^k

0.991 ^k

0.809 ^k

0.704 ^k

Adjuvant therapy

 Chemotherapy

9

2

62.6 (6.32)

71.52 (8.35)

70.3 (10.05)

64.77 (7.54)

66.52 (6.08)

 Radiotherapy

24

6

64.29 (12.53)

71.44 (12.43)

72.44 (16.49)

64.08 (11.83)

67.03 (10.03)

 Chemotherapy and radiotherapy

17

10

65.71 (12.45)

71.36 (11.26)

70.12 (19.16)

63.61 (12.45)

66.98 (10.69)

 None

9

4

66.59 (10.84)

70.51 (8.26)

71.28 (15.49)

64.23 (7.1)

67.37 (6.88)

 p-value

0.450^Q

0.687 ^k

0.957 ^k

0.981 ^k

0.894 ^k

0.993 ^k

Reconstruction technique

 TRAM flap

3

74.29 (17.38)

76.67 (6.67)

62.22 (25.24)

65 (10.9)

70.28 (11.82)

 Myocutaneous flaps of the Latissimus Dorsi Muscle with breast implants

19

66.57 (8.7)

73 (10.7)

79 (16.08)

66.5 (11.65)

69.71 (8.29)

 Subpectoral silicone implants

23

63.81 (12.83)

70 (9.56)

69.14 (12.56)

63.61 (9.94)

65.96 (8.4)

 Subpectoral tissue expanders

6

66.94 (12.33)

73.81 (10.44)

71.43 (19.52)

61.79 (11.25)

67.5 (11.1)

 Another technique

2

62.86 (20.2)

66.67 (14.14)

80 (18.86)

68.75 (22.98)

67.92 (19.45)

 p-value

0.646 ^k

0.721 ^k

0.203 ^k

0.751 ^k

0.635 ^k

Momento of breast reconstruction

 Immediate

36

63.83 (12.35)

70.24 (10.31)

73.01 (15.2)

64.82 (11.34)

66.91 (9.67)

 Delayed

17

69.68 (9.3)

75 (8.5)

72.22 (17.6)

64.17 (10.04)

69.49 (7.26)

 Nonreconstruction

28

62.99 (10.71)

70.15 (12.91)

66.97 (17.39)

62.5 (10.55)

65.11 (9.76)

 p-value

0.084 ^k

0.228 ^k

0.382 ^k

0.611 ^k

0.327 ^k

Complications

 Mastectomy

6

54.76 (9.97)^a

65.71 (12.87)

61.9 (23.32)

59.29 (9.97)

59.76 (10.84)

 Immediate reconstruction

17

64.87 (13.54)^a.b

69.17 (5.56)

65.83 (9.72)

60.94 (7.06)

64.69 (6.41)

 Delayed reconstruction

7

73.88 (9.82)^b

73.33 (8.82)

68.89 (7.7)

55.83 (10.1)

63.06 (9.18)

 None

29

22

64.87 (10.32)^a.b

73.06 (10.58)

75.56 (19.56)

66.88 (11.97)

71.18 (10.14)

 p-value

0.017 ^k

0.248 ^k

0.539 ^k

0.792 ^k

0.359 ^k